查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529836

全球戊型肝炎诊断测试市场：市场规模、份额、趋势分析 - 按类型、最终用途、按地区、细分市场预测，2024-2030 年

Hepatitis E Diagnostic Tests Market Size, Share & Trends Analysis Report By Type (ELISA HEV IgM Test, Rapid Diagnostics Test), By End Use (Hospitals, Blood Banks), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

戊型肝炎诊断测试的市场趋势

预计2023年全球戊型肝炎诊断检测市场规模将达5,475万美元，2024年至2030年复合年增长率为4.77%。这一增长归因于戊型肝炎盛行率的上升、人们对早期检测必要性的认识不断提高以及诊断技术的进步。根据世界卫生组织 (WHO) 统计，全球每年约有 2,000 万人感染戊型肝炎病毒 (HEV)，导致约 330 万有症状的戊型肝炎病例。

近年来，全球市场取得了显着的技术进步，提高了诊断解决方案的准确性、效率和可近性。例如，2021 年 6 月，DiaSorin 宣布推出全自动高通量 CLIA 诊断解决方案。 DiaSorin 的新提案代表了戊型肝炎诊断的重大进步。全自动 CLIA（化学冷光免疫检测）平台可实现高通量测试，使医疗保健提供者能够有效筛检和诊断大量患者。这在戊型肝炎流行率较高的地区尤其重要，快速识别感染者的能力对于有效的疾病控制和预防至关重要。这种先进诊断平台的出现恰逢对准确、高效戊型肝炎检测解决方案不断增长的需求。

努力提高医疗保健提供者、高风险族群和公众的意识对于推动市场成长也很重要。人们对戊型肝炎的风险和后果（包括孕妇死亡率增加）的认识不断提高，推动了对准确诊断测试的需求。将戊型肝炎检测纳入世界卫生组织 2023 年基本诊断清单反映了世界对戊型肝炎早期检测和管理重要性的日益认识。

各国政府和医疗保健系统正在认识到改善监测和疫情管理的必要性，并正在增加 HEV 诊断套件的采购。患者和临床医生也要求更多地获得戊型肝炎检测，以实现早期诊断和及时治疗，进一步推动市场成长。例如，印度政府的国家病毒性肝炎综合控制计划旨在透过注重预防、诊断和治疗的多方面方法来解决包括戊型肝炎在内的所有形式的病毒性肝炎的负担。该计划利用大量政府资金和分散实施策略来加强卫生保健系统有效管理病毒性肝炎的能力。

医疗保健支出的增加，特别是在新兴市场，正在支撑市场成长。对早期检测和有效疾病管理的日益重视正在增加对诊断测试的需求。随着人们对疾病的认识不断增强，人们开始重视实施个人卫生、安全水源、良好卫生习惯和食品安全等预防措施，以减少病毒的传播。

全球戊型肝炎诊断测试市场报告细分

该报告预测了全球、区域和国家层面的收益成长，并对 2018 年至 2030 年各子区隔的最新行业趋势进行了分析。在这项研究中，Grand View Research 根据类型、最终用途和地区对全球戊型肝炎诊断测试市场报告进行了细分。

  • 类型展望（收益，百万美元，2018-2030）
  • ELISA HEV IgM 检测
  • ELISA HEV IgG 检测
  • 快速诊断测试
  • 聚合酵素链锁反应(PCR)
  • 最终用途展望（收益，百万美元，2018-2030）
  • 医院
  • 诊断实验室
  • 血库
  • 其他最终用户
  • 区域展望（收益，百万美元，2018-2030）
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章 戊型肝炎诊断检测市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 戊型肝炎诊断测试市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • 管道分析

第四章戊型肝炎诊断检测市场：类型估计和趋势分析

  • 全球戊型肝炎诊断测试市场：类型仪表板
  • 全球戊型肝炎诊断测试市场：类型分析
  • 全球戊型肝炎诊断测试市场：按类型和收益
  • ELISA HEV IgM 检测
  • ELISA HEV IgG 测试
  • 快速诊断测试
  • 聚合酵素链锁反应(PCR)

第五章戊型肝炎诊断检测市场：最终用途估计与趋势分析

  • 全球戊型肝炎诊断测试市场：最终用途仪表板
  • 全球戊型肝炎诊断测试市场：最终用途变异分析
  • 全球戊型肝炎诊断测试市场：按最终用途分類的收益
  • 医院
  • 诊断实验室
  • 血库
  • 其他用途

第六章戊型肝炎诊断检测市场：区域估计与趋势分析

  • 区域仪表板
  • 2018-2030年市场规模、预测趋势分析：
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第七章 竞争格局

  • 公司/竞争对手分类
  • 供应商情况
    • List of key distributors and channel partners
    • Key customers
    • Key company market share analysis, 2023
    • Wantai BioPharm
    • MP Biomedicals LLP
    • PerkinElmer, Inc
    • DIa.Pro diagnostic Bioprobes srl
    • ELITechGroup
    • Primerdesign Ltd
    • F.Hoffmann-La Roche Ltd
    • Mikrogen GmbH
    • Altona Diagnostics
    • Fortress Diagnostics
Product Code: GVR-4-68040-373-5

Hepatitis E Diagnostic Tests Market Trends

The global hepatitis E diagnostic tests market size was estimated at USD 54.75 million in 2023 and is projected to grow at a CAGR of 4.77% from 2024 to 2030. This growth is attributed to the rising incidences of hepatitis E, increased awareness about the need for early detection, and advancement in diagnostic technologies. According to the World Health Organization (WHO), approximately 20 million people worldwide are infected with the hepatitis E virus (HEV) each year, leading to approximately 3.3 million cases of symptomatic hepatitis E.

The global market has witnessed significant technological advancements in recent years, driving improvements in the accuracy, efficiency, and accessibility of diagnostic solutions. For Instance, in June 2021, DiaSorin introduced the fully automated high-throughput CLIA solution for diagnosis, available in countries that accept the CE market. DiaSorin's new offering represents a significant advancement in hepatitis E diagnostics. The fully automated CLIA (Chemiluminescence Immunoassay) platform enables high-throughput testing, allowing healthcare providers to screen and diagnose many patients efficiently. This is particularly important in regions with a high prevalence of hepatitis E, where the ability to identify infected individuals rapidly is crucial for effective disease management and prevention. The availability of such advanced diagnostic platforms aligns with the growing demand for accurate and efficient hepatitis E testing solutions.

Efforts to raise awareness among healthcare providers, at-risk populations, and the general public are also significant in driving market growth. Greater awareness about the risks and consequences of hepatitis E, such as the higher mortality rates in pregnant women, is fueling the demand for accurate diagnostic tests. The inclusion of hepatitis E tests in the WHO's 2023 Essential Diagnostics List reflects the increasing global recognition of the importance of early detection and management of hepatitis E.

Governments and healthcare systems recognize the need for improved surveillance and outbreak management, leading to increased procurement of HEV diagnostic kits. Patients and clinicians also seek better access to hepatitis E tests to enable early diagnosis and timely treatment, further boosting market growth. For instance, the Government of India comprehensive National Viral Hepatitis Control Program aims to address the burden of all forms of viral hepatitis, including Hepatitis E, through a multi-pronged approach focused on prevention, diagnosis, and treatment. The program involves significant government funding and a decentralized implementation strategy to strengthen the healthcare system's capacity to manage viral hepatitis effectively.

The increasing healthcare expenditure, particularly in emerging markets, is supporting the market growth. The growing emphasis on early detection and effective disease management is driving the demand for diagnostic tests. As awareness about the disease increases, there is a greater focus on implementing preventive measures such as personal hygiene, safe water sources, proper sanitation, and food safety to curb the spread of the virus.

Global Hepatitis E Diagnostic Tests Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global hepatitis E diagnostic tests market report based on type, end use, and region.

  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • ELISA HEV IgM Test
  • ELISA HEV IgG Test
  • Rapid Diagnostics Test
  • Polymerase Chain Reaction (PCR)
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospital
  • Diagnostics Laboratories
  • Blood Banks
  • Other End User
  • Regional Outlook (Revenue in USD Million, 2018 - 2030)
  • North America

U.S.

Canada

Mexico

  • Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

  • Asia Pacific

Japan

China

India

Australia

South Korea

Thailand

  • Latin America

Brazil

Argentina

  • Middle East and Africa

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Test outlook
    • 2.2.2. End Use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Hepatitis E Diagnostic Tests Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising incidences of hepatitis E
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Efforts to raise awareness
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lack of awareness and access to Hepatitis E testing in developing regions
  • 3.3. Hepatitis E Diagnostic Tests Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pipeline Analysis

Chapter 4. Hepatitis E Diagnostic Tests Market: Treatment Estimates & Trend Analysis

  • 4.1. Global Hepatitis E Diagnostic Tests Market: Type Dashboard
  • 4.2. Global Hepatitis E Diagnostic Tests Market: Type Analysis
  • 4.3. Global Hepatitis E Diagnostic Tests Market by Type, Revenue
  • 4.4. ELISA HEV IgM Test
    • 4.4.1. ELISA HEV IgM Test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. ELISA HEV IgG Test
    • 4.5.1. ELISA HEV IgG Test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Rapid Diagnostics Test
    • 4.6.1. Rapid Diagnostics Test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Polymerase Chain Reaction (PCR)
    • 4.7.1. Polymerase Chain Reaction (PCR) market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Hepatitis E Diagnostic Tests Market: End Use Estimates & Trend Analysis

  • 5.1. Global Hepatitis E Diagnostic Tests Market: End Use Dashboard
  • 5.2. Global Hepatitis E Diagnostic Tests Market: End Use Movement Analysis
  • 5.3. Global Hepatitis E Diagnostic Tests Market Estimates and Forecasts, By End Use, Revenue (USD Million)
  • 5.4. Hospital
    • 5.4.1. Hospital market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Diagnostics Laboratories
    • 5.5.1. Diagnostic Laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Blood Banks
    • 5.6.1. Blood Banks market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Other End Use
    • 5.7.1. Other End Use market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Hepatitis E Diagnostic Tests Market: Regional Estimates & Trend Analysis by Type and End Use

  • 6.1. Regional Dashboard
  • 6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.3. North America
    • 6.3.1. U.S.
      • 6.3.1.1. Key country dynamics
      • 6.3.1.2. Regulatory framework/ reimbursement structure
      • 6.3.1.3. Competitive scenario
      • 6.3.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.3.2. Canada
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.3.3. Mexico
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.3. France
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.6. Norway
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.5.3. India
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.6.2. Argentina
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization
  • 7.2. Vendor Landscape
    • 7.2.1. List of key distributors and channel partners
    • 7.2.2. Key customers
    • 7.2.3. Key company market share analysis, 2023
    • 7.2.4. Wantai BioPharm
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. MP Biomedicals LLP
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. PerkinElmer, Inc
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. DIa.Pro diagnostic Bioprobes srl
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. ELITechGroup
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Primerdesign Ltd
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. F.Hoffmann-La Roche Ltd
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
    • 7.2.11. Mikrogen GmbH
      • 7.2.11.1. Company overview
      • 7.2.11.2. Financial performance
      • 7.2.11.3. Product benchmarking
      • 7.2.11.4. Strategic initiatives
    • 7.2.12. Altona Diagnostics
      • 7.2.12.1. Company overview
      • 7.2.12.2. Financial performance
      • 7.2.12.3. Product benchmarking
      • 7.2.12.4. Strategic initiatives
    • 7.2.13. Fortress Diagnostics
      • 7.2.13.1. Company overview
      • 7.2.13.2. Financial performance
      • 7.2.13.3. Product benchmarking
      • 7.2.13.4. Strategic initiatives

List of Tables

  • Table 1 List Of Abbreviation
  • Table 2 North America Hepatitis E Diagnostic Tests Market, By Region, 2018 - 2030 (USD Million)
  • Table 3 North America Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 4 North America Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 5 U.S. Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 6 U.S. Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 7 Canada Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 8 Canada Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 9 Mexico Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 10 Mexico Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 11 Europe Hepatitis E Diagnostic Tests Market, By Region, 2018 - 2030 (USD Million)
  • Table 12 Europe Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 13 Europe Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 14 Germany Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 15 Germany Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 16 UK Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 17 UK Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 18 France Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 19 France Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 20 Italy Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 21 Italy Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 22 Spain Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 23 Spain Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 24 Denmark Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 25 Denmark Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 26 Sweden Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 27 Sweden Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 28 Norway Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 29 Norway Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific Hepatitis E Diagnostic Tests Market, By Region, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 33 China Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 34 China Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 35 Japan Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 36 Japan Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 37 India Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 38 India Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 39 South Korea Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 40 South Korea Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 41 Australia Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 42 Australia Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 43 Thailand Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 44 Thailand Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 45 Latin America Hepatitis E Diagnostic Tests Market, By Region, 2018 - 2030 (USD Million)
  • Table 46 Latin America Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 47 Latin America Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 48 Brazil Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 49 Brazil Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 50 Argentina Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 51 Argentina Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 52 MEA Hepatitis E Diagnostic Tests Market, By Region, 2018 - 2030 (USD Million)
  • Table 53 MEA Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 54 MEA Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 55 South Africa Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 56 South Africa Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 59 UAE Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 60 UAE Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait Hepatitis E Diagnostic Tests Market, By Type, 2018 - 2030 (USD Million)
  • Table 62 Kuwait Hepatitis E Diagnostic Tests Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Hepatitis E diagnostic tests market outlook
  • Fig. 14 Hepatitis E diagnostic tests competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Hepatitis E diagnostic tests market driver impact
  • Fig. 18 Hepatitis E diagnostic tests market restraint impact
  • Fig. 19 Hepatitis E diagnostic tests market: Type movement analysis
  • Fig. 20 Hepatitis E diagnostic tests market: Type outlook and key takeaways
  • Fig. 21 ELISA HEV IgM test market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 ELISA HEV IgG test market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Rapid Diagnostics test market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Polymerase Chain Reaction (PCR) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Hepatitis E diagnostic tests market: End Use movement analysis
  • Fig. 26 Hepatitis E diagnostic tests market: End Use outlook and key takeaways
  • Fig. 27 Hospital market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Diagnostic Laboratories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Blood Banks market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Other End User market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Hepatitis E diagnostic tests market: Regional movement analysis
  • Fig. 32 Hepatitis E diagnostic tests market: Regional outlook and key takeaways
  • Fig. 33 Hepatitis E diagnostic tests market share and leading players
  • Fig. 34 North America, by country
  • Fig. 35 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 US key country dynamics
  • Fig. 37 US market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Canada key country dynamics
  • Fig. 39 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Mexico key country dynamics
  • Fig. 41 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 UK key country dynamics
  • Fig. 44 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Germany key country dynamics
  • Fig. 46 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 France key country dynamics
  • Fig. 48 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Italy key country dynamics
  • Fig. 50 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Spain key country dynamics
  • Fig. 52 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Denmark key country dynamics
  • Fig. 54 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Sweden key country dynamics
  • Fig. 56 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Norway key country dynamics
  • Fig. 58 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 China key country dynamics
  • Fig. 61 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Japan key country dynamics
  • Fig. 63 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 India key country dynamics
  • Fig. 65 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Thailand key country dynamics
  • Fig. 67 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 South Korea key country dynamics
  • Fig. 69 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Australia key country dynamics
  • Fig. 71 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Brazil key country dynamics
  • Fig. 74 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Argentina key country dynamics
  • Fig. 76 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 South Africa key country dynamics
  • Fig. 79 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Saudi Arabia key country dynamics
  • Fig. 81 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 UAE key country dynamics
  • Fig. 83 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Kuwait key country dynamics
  • Fig. 85 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Market share of key market players- Hepatitis E Diagnostic Tests market